Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimos D Mitsikostas

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Multiple Sclerosis and Related Disorders|November 17, 2017
Comparing the efficacy of disease-modifying therapies in multiple sclerosisDimos D Mitsikostas, Douglas S Goodin
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultationDimos D Mitsikostas, Christina I Deligianni
Current Opinion in Neurology|June 8, 2022
Therapies targeting CGRP signaling for medication overuse headacheIoannis-Alexios Koumprentziotis, Dimos D Mitsikostas
BMC Medicine|November 12, 2015
New players in the preventive treatment of migraineDimos D Mitsikostas, Alan M Rapoport
Nature Reviews. Neurology|November 17, 2020
Making headway - a role for CGRP in post-traumatic headacheDimos D Mitsikostas, Michael A Moskowitz
Handbook of Clinical Neurology|February 2, 2024
Evidence-based symptomatic treatment of migraineDimos D Mitsikostas, Thomas N Ward
Headache|July 24, 2010
Sleep and headache: the clinical relationshipDimos D Mitsikostas, Alexandros Viskos, Dimitrios Papadopoulos
Multiple Sclerosis and Related Disorders|September 17, 2019
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatmentsPanagiotis Gklinos, Dimitrios Papadopoulos, Dimos D Mitsikostas
Frontiers in Pharmacology|August 10, 2019
Nocebo in Biosimilars and Generics in Neurology: A Systematic ReviewIoanna Spanou, Theodoros Mavridis, Dimos D Mitsikostas
Headache|September 12, 2019
Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?Piero Barbanti, Gabriella Egeo, Dimos D Mitsikostas
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis and Related Disorders|November 17, 2017
Comparing the efficacy of disease-modifying therapies in multiple sclerosisDimos D Mitsikostas, Douglas S Goodin
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2014
Q-No: a questionnaire to predict nocebo in outpatients seeking neurological consultationDimos D Mitsikostas, Christina I Deligianni
Current Opinion in Neurology|June 8, 2022
Therapies targeting CGRP signaling for medication overuse headacheIoannis-Alexios Koumprentziotis, Dimos D Mitsikostas
BMC Medicine|November 12, 2015
New players in the preventive treatment of migraineDimos D Mitsikostas, Alan M Rapoport
Nature Reviews. Neurology|November 17, 2020
Making headway - a role for CGRP in post-traumatic headacheDimos D Mitsikostas, Michael A Moskowitz
Handbook of Clinical Neurology|February 2, 2024
Evidence-based symptomatic treatment of migraineDimos D Mitsikostas, Thomas N Ward
Headache|July 24, 2010
Sleep and headache: the clinical relationshipDimos D Mitsikostas, Alexandros Viskos, Dimitrios Papadopoulos
Multiple Sclerosis and Related Disorders|September 17, 2019
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatmentsPanagiotis Gklinos, Dimitrios Papadopoulos, Dimos D Mitsikostas
Frontiers in Pharmacology|August 10, 2019
Nocebo in Biosimilars and Generics in Neurology: A Systematic ReviewIoanna Spanou, Theodoros Mavridis, Dimos D Mitsikostas
Headache|September 12, 2019
Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?Piero Barbanti, Gabriella Egeo, Dimos D Mitsikostas
Pageof 10